Hao Zhang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Vascular Endothelial Growth Factor

Protein Protein

Top Venues

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Zhou, Zhimeng Yao, Yusheng Lin, Hao Zhang
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond. Pharmaceutics 16 (7) (2024)
Yu Zhou, Zhimeng Yao, Yusheng Lin, Hao Zhang
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond. Pharmaceutics 16 (7) (2024)
Yu Zhou, Zhimeng Yao, Yusheng Lin, Hao Zhang
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond. Pharmaceutics 16 (7) (2024)
Emily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Isabel Britsch, Anne Paulien van Wijngaarden, Hao Zhang, Wijnand Helfrich
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR. Journal for immunotherapy of cancer 11 (9) (2023)
Kai Li, Yusheng Lin, Yichen Luo, Xiao Xiong, Lu Wang, Kameron Durante, Junkuo Li, Fuyou Zhou, Yi Guo, Shaobin Chen, Yuping Chen, Dianzheng Zhang, Sai-Ching Jim Yeung, Hao Zhang
A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Molecular cancer 21 (1) (2022)
Jianlin Zhu, Lu Wang, Fan Liu, Jinghua Pan, Zhimeng Yao, Yusheng Lin, Yabing Yang, Xiao Xiong, Kai Li, Yi Yang, Yiran Zhang, Xiaodong Chu, Yunlong Pan, Hao Zhang
Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer. Cancers 14 (2) (2022)
Shasha Cao, Xiaomin Wang, Xiaohui Liu, Junkuo Li, Lijuan Duan, Zhaowei Gao, Shumin Lun, Yanju Zhu, Haijun Yang, Hao Zhang, Fuyou Zhou
Integrative Analysis of Angiogenesis-Related Long Non-Coding RNA and Identification of a Six-DEARlncRNA Signature Associated with Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma. Cancers 14 (17) (2022)
Yichen Luo, Liang Du, Zhimeng Yao, Fan Liu, Kai Li, Feifei Li, Jianlin Zhu, Robert P Coppes, Dianzheng Zhang, Yunlong Pan, Shegan Gao, Hao Zhang
Generation and Application of Inducible Chimeric RNA ASTN2-PAPPA as Knockin Mouse Model. Cells 11 (2) (2022)
Lu Wang, Liang Du, Xiao Xiong, Yusheng Lin, Jianlin Zhu, Zhimeng Yao, Shuhong Wang, Yi Guo, Yuping Chen, Kyla Geary, Yunlong Pan, Fuyou Zhou, Shegan Gao, Dianzheng Zhang, Sai-Ching Jim Yeung, Hao Zhang
Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Oncogene 40 (11) (2021)
Yusheng Lin, Shuhong Wang, Edwin Bremer, Hao Zhang
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low-dose metformin. Cancer communications (London, England) 41 (8) (2021)
Xiao Wu, Xiurong Ke, Yangpeng Ni, Liping Kuang, Fan Zhang, Yusheng Lin, Wan Lin, Xiao Xiong, Haihua Huang, Xianjie Lin, Hao Zhang
Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell Carcinoma. Journal of immunology research 2020 (2020)
Xingli Dong, Xupeng Bai, Jie Ni, Hao Zhang, Wei Duan, Peter Graham, Yong Li
Exosomes and breast cancer drug resistance. Cell death & disease 11 (11) (2020)
Lu Wang, Weiwei Li, Kai Li, Yi Guo, Ditian Liu, Zhimeng Yao, Xianjie Lin, Shujun Li, Zuojie Jiang, Qing Liu, Yi Jiang, Beien Zhang, Lei Chen, Fuyou Zhou, Hongzheng Ren, Danxia Lin, Dianzheng Zhang, Sai-Ching Jim Yeung, Hao Zhang
The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer medicine 7 (10) (2018)